Non-neoplastic renal diseases are often unrecognized in adult tumor nephrectomy specimens: A review of 246 cases

被引:66
作者
Henriksen, Kanuni J. [1 ]
Meehan, Shane M. [1 ]
Chang, Anthony [1 ]
机构
[1] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
关键词
renal neoplasm; nephrectomy; medical renal pathology; diabetic nephropathy;
D O I
10.1097/PAS.0b013e31804ca63e
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The pathologic evaluation of tumor nephrectomy specimens focuses on the diagnosis, grading, and staging of the neoplasm. The presence of coincidental non-neoplastic diseases in these specimens may have significant implications for patient outcomes. The purpose of this study is to determine the spectrum of non-neoplastic disease processes that may be overlooked in tumor nephrectomies, and to ascertain the extent to which surgical pathologists are trained to recognize these lesions. We reviewed the hematoxylin and eosin-stained slides of 246 adult tumor nephrectomy specimens with an emphasis on the non-neoplastic renal parenchyma. Further analysis of cases with pathologic alterations included special stains and direct immunofluorescence microscopy. The surgical pathology reports were reviewed to determine whether the non-neoplastic lesions were originally identified. We also surveyed United States pathology residency programs to determine how many require training in medical renal pathology. Forty-one cases (16.7%) had alterations, such as diffuse and/or nodular mesangial sclerosis, mesangial hypercellularity, or glomerular basement membrane thickening that warranted further study. After further work-up and clinical correlation, the pathologic changes in 24 cases were categorized as follows: diabetic nephropathy (19 cases) of which one demonstrated atheroembolic disease, thrombotic microangiopathy (3 cases), sickle cell nephropathy (I case), and focal segmental glomeruloselerosis (I case). Twenty-one (88%) of these diagnoses were not identified at initial pathologic evaluation. Only 35 of 98 pathology residency programs that responded to our survey require any formal training in medical renal pathology. Although accurate pathologic evaluation of renal neoplasms remains essential, surgical pathologists should be aware that coincidental nonneoplastic renal diseases are common, often not recognized, and may have important implications for patient care. Further consideration should be given to the training requirements of pathology residents and the guidelines for evaluation of nephrectomy specimens to avoid missing non-neoplastic renal lesions.
引用
收藏
页码:1703 / 1708
页数:6
相关论文
共 16 条
  • [1] *ADASP, 2003, ADASP CHECKL GUID SU
  • [2] RENAL IMMUNOPATHOLOGY IN RENAL-CELL CARCINOMA
    BEAUFILS, H
    PATTE, R
    AUBERT, P
    CAMEY, M
    KUSS, R
    BARBAGELATTA, M
    CHOMETTE, G
    [J]. VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1984, 404 (01) : 87 - 97
  • [3] Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens -: Predicting the risk of progressive renal failure
    Bijol, V
    Mendez, GP
    Hurwitz, S
    Rennke, HG
    Nosé, V
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (05) : 575 - 584
  • [4] THE EFFECTS OF PANCREAS TRANSPLANTATION ON THE GLOMERULAR STRUCTURE OF RENAL-ALLOGRAFTS IN PATIENTS WITH INSULIN-DEPENDENT DIABETES
    BILOUS, RW
    MAUER, SM
    SUTHERLAND, DER
    NAJARIAN, JS
    GOETZ, FC
    STEFFES, MW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (02) : 80 - 85
  • [5] BUDIN RE, 1984, ARCH PATHOL LAB MED, V108, P138
  • [6] PARAFFIN-PROCESSED MATERIAL IS UNSUITABLE FOR DIAGNOSIS OF THIN-MEMBRANE DISEASE
    COLLAR, J
    CATTELL, V
    [J]. NEPHRON, 1995, 69 (02): : 187 - 188
  • [7] COLLINS AJ, 2005, AM J KIDNEY DIS, V45, pS121
  • [8] DAGATI VD, 2005, NONNEOPLASTIC KIDNEY, P300
  • [9] Renal protection in diabetes: Role of glycemic control
    Fioretto, Paola
    Bruseghin, Marino
    Berto, Ilaria
    Gallina, Pietro
    Manzato, Enzo
    Mussap, Michele
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (04): : S86 - S89
  • [10] Huang WC, 2006, LANCET ONCOL, V7, P735, DOI 10.1016/S1470-2045(06)70803-8